This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Endpoints News
endpts.com
did:plc:l5aan5lkmuqstilgyczaho3v
Novartis is returning to Huntington’s disease with a $1 billion upfront bet, plus another $1.9 billion in biobucks, for access to a Phase 2 oral drug.
https://endpts.com/novartis-pays-1b-upfront-for-ptcs-phase-2-huntingtons-drug/?utm_medium=organic_social&utm_campaign=gatedarticle&utm_source=bluesky&utm_content=&utm_term=
2024-12-02T13:13:57.051Z